Evaluation of thermal stability of indinavir sulphate using diffuse reflectance infrared spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 47, Issue 2, 2008, Pages 248-254

  Singh, Parul ^a   Premkumar, L ^a   Mehrotra, Ranjana ^a   Kandpal, H C ^a   Bakhshi, A K ^b  

^a NATIONAL PHYSICAL LABORATORY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Diffuse reflectance; HIV protease inhibitors; ICH; Indinavir sulphate; Infrared spectroscopy; Thermal stability

Indexed keywords

INDINAVIR;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSE REFLECTANCE SPECTROSCOPY; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; HEAT TREATMENT; HIGH TEMPERATURE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; THERMOGRAVIMETRY; THERMOSTABILITY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG STABILITY; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MOLECULAR STRUCTURE; POWDER DIFFRACTION; SPECTROPHOTOMETRY, INFRARED; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 43049131756     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.01.001     Document Type: Article

References (28)

1. Barry M., Gibbons S., Back D., and Mulcahy F. Clin. Pharmacokinet. 32 (1997) 194-209
2. Deeks S.G., Smith M., Holodnity M., and Kahn J.O. J. Am. Med. Assoc. 277 (1977) 145-153
3. E.M.E.A., www.emea.europa.eu/humandocs/PDFs/EPAR/Crixivan/058996en6.pdf, 2005.
4. Kreuz D.M., Howard A.L., and Lp D. J. Pharm. Biomed. Anal. 19 (1999) 725-735
5. Demir A.S., Hamamei H., Goganel F., and Ozgul E. J. Mol. Catal. B: Enzym. 9 (2000) 157-161
6. Aymard G., Legrand M., Trichereau N., and Diquet B. J. Chromatogr. B 744 (2000) 227-240
7. Zhong L., and Yeh K.C. J. Chromatogr. B 734 (1999) 63-71
8. Frerichs V.A., Difrancesco R., and Morse G.D. J. Chromatogr. B 787 (2003) 393-403
9. Foisy M.L., and Sommdossi J.P. J. Chromatogr. B 721 (1999) 239-247
10. Jayewardene A.L., Kearney B., and Stone J.A. J. Pharm. Biomed. Anal. 25 (2001) 309-317
11. Woolf E.J., and Matuszewski B.K. J. Pharm. Biomed. Anal. 18 (1998) 347-357
12. Gutleben W., Tuan N.D., Stoiber H., Dierich M.P., and Zemann A. J. Chromatogr. A 982 (2002) 153-161
13. Tuan N.D., Gutleben W., Scherer K., Stoiber H., Falkensammer B., Dierich M.P., and Zemann A. Electrophoresis 24 (2003) 662-670
14. Chelyapov N., Jcobs S.A., and Magee T.J. J. Chromatogr. A 853 (1999) 431-437
15. Johnson B.D., Howard A., Varasolona R., McCauley J., and Ellison D.K. In: Brittain G. (Ed). Analytical Profiles of Drug Substances and Excipients Vol. 26 (1996), Academic Press, San Diego, CA 319-358
16. Consultation document of International Pharmacopoeia, WHO Drug Information, Geneva, Switzerland, Vol. 19, 2005, pp. 51-55.
17. Aurora Pado M.S., Kedor-Hackmann E.R.M., Santoro M.I.R.M., Pinto T.J.A., and Tavares M.F.M. J. Pharm. Biomed. Anal. 34 (2004) 441-450
18. Jancic B., Medenica M., Ivanovic D., and Malenovic A. Chromatographia 62 (2005) 233-238
19. Silva B.C.E., de campos L.M.M., Nunan E.A., Soores C.D.V., Silva C.R., Ribeiro J.A.A., and Pianetti G.A. Quim. Nova 28 (2005) 50-53
20. I.C.H. Proceedings of International Conference on Harmonisation IFPMA. Geneva (October 2003)
21. Kaul N., Agrawal H., Paradkar K.R., and Mahadik A.R. IL Farmaco 59 (2004) 729-738
22. Teraoka R., Akoto Otsuka M., and Matsuda Y. Int. J. Pharm. 286 (2004) 1-8
23. Matsuda Y., Akazawa R., Teraoka R., and Otsuka M. J. Pharm. Pharmacol. 46 (1994) 162-167
24. Teraoka R., Matsuda M., and Matsuda Y. Int. J. Pharm. 184 (1999) 35-43
25. Markovic N., Agotonovic-Kustrin S., Glass B., and Prestidge C.A. J. Pharm. Biomed. Anal. 42 (2006) 25-31
26. Clas S.D., Dalton C.R., and Hancock B.C. Encyclopedia of Pharmaceutical Technology (2002), Marcel Decker Inc. p. 289
27. Merck Index, 2001, p. 889.
28. Socrates G. Infrared Characteristic Group Frequencies. 2nd edition (1994), John Wiley & Sons, England